-
Boston Scientific's Use Of Adjusted Earnings Distorts Valuations
Post on 4/24/19
-
Lawrence General Hospital RNs Reach Tentative Agreement
Post on 4/23/19
-
Verastem Oncology Announces Amendment to Refinance Hercules Loan Facility
Post on 4/23/19
-
Mispro Launches Insourcing Services for Vivarium Research Facilities
Post on 4/23/19
-
Sherlock Biosciences Closes $31M Series A
Post on 4/23/19
-
Stewart’s Ambulance Service/Transformative Healthcare Expands into 4 Maine and N.H. Seacoast Communities
Post on 4/23/19
-
IPO Update: Trevi Therapeutics Proposes IPO Terms
Post on 4/23/19
-
Better Buy: Biogen vs. AbbVie
Post on 4/23/19
-
TransMedics Group On Deck For IPO
Post on 4/22/19
-
Better Buy: Walgreens Boots Alliance vs. CVS Health
Post on 4/22/19
-
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Post on 4/18/19
-
Indalo Therapeutics Initiates Dosing in Phase 1 Clinical Trial of Lead Antifibrotic Drug Candidate IDL-2965
Post on 4/18/19
-
Arrakis Therapeutics Raises $75M Series B Financing
Post on 4/18/19
-
Talaris Therapeutics Raises $100M Series A Financing
Post on 4/18/19
-
Here's Why Shares of bluebird bio Slumped Today
Post on 4/18/19
-
Owl Labs Raises $15M in Series B Funding
Post on 4/17/19
-
PureTech Health Announces Collaboration with Boehringer Ingelheim
Post on 4/17/19
-
2019’s Best & Worst States for Children’s Health Care – WalletHub Study
Post on 4/17/19
-
Why Celgene Shareholders Should Hold On to Their Bristol-Myers Squibb Stock Once the Acquisition Closes
Post on 4/17/19
-
Myomo Announces New Sales and Service Agreement for Chile
Post on 4/16/19
-
Twist Bioscience and iGEM Partner
Post on 4/15/19
-
EI Pharma Closes $11.2 Million Financing Round
Post on 4/15/19
-
Better Buy: Gilead Sciences vs. Biogen
Post on 4/15/19
-
Better Buy: GW Pharmaceuticals vs. Cara Therapeutics
Post on 4/15/19
-
Bristol-Myers Squibb Shareholders Approve Celgene Acquisition
Post on 4/15/19